13D·WATCH Activist + Insider Intelligence Live feed Blog About Pricing
SCHEDULE 13G Filed 2026-06-23 Event — SEC 0001013594-26-000689 →

Madison Avenue Partners, LP Lakefront Biotherapeutics NV GLPGF

Stake: Shares: Class: Ordinary shares, no nominal value per share (the "Ordinary Shares")

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)
0 transactions
0 buys · 0 sales · 0 awards/exercises
Issuer Cluster
5 13D/G filings on this issuer
4 other filings besides this one
Filer Track Record
2 filings by this filer
1 other filing in the data moat
Short Interest · settle 2026-07-31
DTC 999.99
591,991 shares short · +0.6% vs prior

Other 13D/G Filings on Lakefront Biotherapeutics NV

FiledFormFilerStakeShares
2025-05-19 SCHEDULE EcoR1 Capital, LLC 11.84% 7,803,202 view →
2025-01-10 SCHEDULE GILEAD SCIENCES, INC. 29.90% 20,981,010 view →
2024-10-08 SC EcoR1 Capital, LLC view →
2019-08-29 SC GILEAD SCIENCES INC view →

Other Filings by Madison Avenue Partners, LP

FiledFormIssuerStakeShares
2021-05-27 SC LEAF GROUP LTD. view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →